The primary endpoint was percent change in body weight from baseline to week 48
Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes
At lower doses, the GLP-1 provides support
Holistic care management Although much of the current cultural discourse about GLP-1s is related to how the medications are used to manage weight, the fact of the matter is most patients (the KFF survey said around six in 10) are taking them to manage diabetes and heart disease
After consulting with a weight loss physician, I hesitantly started taking a glucagon-like peptide-1 (GLP-1) receptor agonist (Zepbound, in my case) approximately two years ago, and, in short, its been life-changing for me in the best way
If you have Medicare and one of these conditions, your prescriber may be able to get coverage through existing Part D pathways